COMMUNICATION
|
doi:10.20944/preprints202003.0395.v1
Subject:
Medicine And Pharmacology,
Medicine And Pharmacology
Keywords:
Novel coronavirus (SARS-CoV-2); RdRp; HCV; beclabuvir; in silico; molecular docking
Online: 26 March 2020 (15:18:38 CET)